Addus HomeCare vs Pennant
ADUS and PNTG side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ADUS and PNTG compare
Addus HomeCare is the larger company, worth 1.8 times as much as Pennant ($2.3B against $1.3B).
On earnings, Addus HomeCare is cheaper: it trades at 20.5× trailing earnings, against 36.4× for Pennant.
Pennant grew revenue faster over the last twelve months (38.7% versus 11.5% for Addus HomeCare).
Addus HomeCare keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with 3.1% at Pennant.
Addus HomeCare scores higher on the StockData Score (20 against 14 for Pennant), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ADUS | PNTG |
|---|---|---|
| Size and price | ||
| Market cap | $2.3B | $1.3B |
| Share price | $123.00 | $36.07 |
| Change, 1 year | 8.2% | 42.9% |
| Change, 5 years | 22.5% | 60.2% |
| Beta (5Y) | 0.54 | 1.06 |
| Employees | 5,290 | 9,700 |
| StockData Score | ||
| Total score | 20 (better) | 14 |
| Valuation score | 5 (better) | 4 |
| Growth score | 4 | 4 |
| Performance score | 5 (better) | 3 |
| Health score | 6 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 20.5× (better) | 36.4× |
| P/S | 1.5× | 1.1× (better) |
| P/B | 1.9× | – |
| EV/EBITDA | 12.9× (better) | 16.1× |
| P/FCF | 15.9× (better) | 36.7× |
| PEG | 0.91 | 0.65 (better) |
| FCF yield | 6.3% (better) | 2.7% |
| Fair value | $144.79 | $37.49 |
| Margin of safety | 15.1% (better) | 3.8% |
| Growth | ||
| Revenue growth (TTM) | 11.5% | 38.7% (better) |
| Revenue growth, 5Y average | 13.2% | 19.4% (better) |
| Net income growth (TTM) | 29.7% | 34.4% (better) |
| EPS growth (TTM) | 28.5% | 32.0% (better) |
| EPS growth, 5Y average | 20.2% (better) | 10.1% |
| Profitability | ||
| Gross margin | 32.3% (better) | 18.3% |
| Operating margin | 10.3% (better) | 5.8% |
| Net margin | 7.4% (better) | 3.1% |
| FCF margin | 9.6% (better) | 2.9% |
| Return on equity | 10.0% | – |
| Return on invested capital | 10.5% | – |
| Financial health | ||
| Debt / equity | 0.02 | – |
| Net debt / EBITDA | −0.45 | −0.17 |
| Interest coverage | 19.7× (better) | 5.2× |
| Current ratio | 1.64 (better) | 1.18 |
| Altman Z-score | 7.11 (better) | 2.74 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 104% | 92.7% |
| Held by insiders | 2.8% | 5.0% |
| Insider net buying, 12 months | −$20.7M | −$690K (better) |
| Short interest, % of float | 5.5% | 3.5% |
Go deeper
- ADUS stock overview
- ADUS income statement
- ADUS valuation and score
- PNTG stock overview
- PNTG income statement
- PNTG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.